相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PSMD12-Mediated M1 Ubiquitination of Influenza A Virus at K102 Regulates Viral Replication
Xianfeng Hui et al.
JOURNAL OF VIROLOGY (2022)
Traditional Chinese medicines as effective agents against influenza virus-induced pneumonia
Mengru Yang et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Influenza Therapeutics in Clinical Practice-Challenges and Recent Advances
John H. Beigel et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2021)
Glycyrrhizic Acid Nanoparticles as Antiviral and Anti-inflammatory Agents for COVID-19 Treatment
Zhaoyan Zhao et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
Silver Nanoparticles as Potential Antiviral Agents
Zubair Ahmed Ratan et al.
PHARMACEUTICS (2021)
3-Indoleacetonitrile Is Highly Effective in Treating Influenza A Virus Infection In Vitro and In Vivo
Xuejin Zhao et al.
VIRUSES-BASEL (2021)
Resistance of Influenza Virus to Antiviral Medications
Richard J. Whitley et al.
CLINICAL INFECTIOUS DISEASES (2020)
Is a Universal Influenza Virus Vaccine Possible?
Raffael Nachbagauer et al.
ANNUAL REVIEW OF MEDICINE, VOL 71, 2020 (2020)
Who and when to vaccinate against influenza
Philippe Buchy et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Glycyrrhizic-Acid-Based Carbon Dots with High Antiviral Activity by Multisite Inhibition Mechanisms
Ting Tong et al.
SMALL (2020)
Challenges of Making Effective Influenza Vaccines
Sigrid Gouma et al.
ANNUAL REVIEW OF VIROLOGY, VOL 7, 2020 (2020)
Structure of avian influenza hemagglutinin in complex with a small molecule entry inhibitor
Aleksandar Antanasijevic et al.
LIFE SCIENCE ALLIANCE (2020)
Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?
Christian Bailly et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Current and future influenza vaccines
Seiya Yamayoshi et al.
NATURE MEDICINE (2019)
High Amplification of the Antiviral Activity of Curcumin through Transformation into Carbon Quantum Dots
Chin-Jung Lin et al.
SMALL (2019)
Investigation of phosphorous doping effects on polymeric carbon dots: Fluorescence, photostability, and environmental impact
Bo Zhi et al.
CARBON (2018)
Highly monodispersed gold nanoparticles synthesis and inhibition of herpes simplex virus infections
Asim Haider et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2018)
Antiviral effects of Shuanghuanglian injection powder against influenza A virus H5N1 in vitro and in vivo
Yuling Tang et al.
MICROBIAL PATHOGENESIS (2018)
Influenza
Florian Krammer et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Glycyrrhizin inhibits porcine epidemic diarrhea virus infection and attenuates the proinflammatory responses by inhibition of high mobility group box-1 protein
Chang-chao Huan et al.
ARCHIVES OF VIROLOGY (2017)
A Sequentially Triggered Nanosystem for Precise Drug Delivery and Simultaneous Inhibition of Cancer Growth, Migration, and Invasion
Ting Liu et al.
ADVANCED FUNCTIONAL MATERIALS (2016)
Enhancement of anti-inflammatory activity of glycyrrhizic acid by encapsulation in chitosan-katira gum nanoparticles
Manju Bernela et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
Global Mortality Impact of the 1957-1959 Influenza Pandemic
Cecile Viboud et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design
Annelies Stevaert et al.
MEDICINAL RESEARCH REVIEWS (2016)
Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials
Joanna Dobson et al.
LANCET (2015)
Nanomaterials for Theranostics: Recent Advances and Future Challenges
Eun-Kyung Lim et al.
CHEMICAL REVIEWS (2015)
Socioeconomic Impact of Seasonal (Epidemic) Influenza and the Role of Over-the-Counter Medicines
Michael E. Klepser
DRUGS (2014)
Glycyrrhizic Acid in the Treatment of Liver Diseases: Literature Review
Jian-yuan Li et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cells
Patchima Sithisarn et al.
ANTIVIRAL RESEARCH (2013)
Recent Advances in Neuraminidase Inhibitor Development as Anti-influenza Drugs
Enguang Feng et al.
CHEMMEDCHEM (2012)
Chinese Herbal Medicines for the Treatment of Type A H1N1 Influenza: A Systematic Review of Randomized Controlled Trials
Wei Chen et al.
PLOS ONE (2011)
Antivirals and resistance: influenza virus
Michael G. Ison
CURRENT OPINION IN VIROLOGY (2011)
Influenza Virus Evolution, Host Adaptation, and Pandemic Formation
Jeffery K. Taubenberger et al.
CELL HOST & MICROBE (2010)
Glycyrrhizin inhibits highly pathogenic H5N1 influenza A virus-induced pro-inflammatory cytokine and chemokine expression in human macrophages
Martin Michaelis et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2010)
Flu channel drug resistance: a tale of two sites
Rafal M. Pielak et al.
PROTEIN & CELL (2010)
Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel
Xianghong Jing et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Use of confocal immunofluorescence microscopy to localize viral nonstructural proteins and potential sites of replication in pigs experimentally infected with foot-and-mouth disease virus
P Monaghan et al.
JOURNAL OF VIROLOGY (2005)
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus
J Cinatl et al.
LANCET (2003)
Updating the accounts: global mortality of the 1918-1920 Spanish influenza pandemic
NPAS Johnson et al.
BULLETIN OF THE HISTORY OF MEDICINE (2002)
分享论文
